Abiopharma

🔍 Leggett Michael Adam (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 7,502 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 49,975.00 | transaction_form_type: 4
• Sold 387 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 49,588.00 | transaction_form_type: 4
• Sold 597 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 48,991.00 | transaction_form_type: 4
• Acquired 1,889 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 50,880.00 | transaction_form_type: 4
• Sold 538 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 50,342.00 | transaction_form_type: 4
• Acquired 5,235 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,577.00 | transaction_form_type: 4
• Sold 1,489 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 54,088.00 | transaction_form_type: 4
• Acquired 1,538 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,626.00 | transaction_form_type: 4
• Acquired 1,451 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,077.00 | transaction_form_type: 4